Results 1 to 10 of about 112,568 (262)

Identification of HIV-1 Reverse Transcriptase-Associated Ribonuclease H Inhibitors Based on 2-Hydroxy-1,4-naphthoquinone Mannich Bases [PDF]

open access: goldMolecules
There is a strong demand for new and efficient antiviral compounds. A series of 2-hydroxy-1,4-naphthoquinone Mannich bases were screened for their HIV-1-RNase H inhibitory activity.
Nhat Quang Tu   +9 more
doaj   +3 more sources

Discovery of Benzisothiazolone Derivatives as Bifunctional Inhibitors of HIV-1 Reverse Transcriptase DNA Polymerase and Ribonuclease H Activities [PDF]

open access: greenBiomolecules
The ribonuclease H (RNase H) active site of HIV-1 reverse transcriptase (RT) is the only viral enzyme not targeted by approved antiretroviral drugs. Using a fluorescence-based in vitro assay, we screened 65,239 compounds at a final concentration of 10 µM
Alondra Vázquez Rivera   +7 more
doaj   +6 more sources

Thermal adaptation of conformational dynamics in ribonuclease H. [PDF]

open access: goldPLoS Computational Biology, 2013
The relationship between inherent internal conformational processes and enzymatic activity or thermodynamic stability of proteins has proven difficult to characterize. The study of homologous proteins with differing thermostabilities offers an especially
Kate A Stafford   +2 more
doaj   +4 more sources

The hepatitis B virus ribonuclease H is sensitive to inhibitors of the human immunodeficiency virus ribonuclease H and integrase enzymes. [PDF]

open access: goldPLoS Pathogens, 2013
Nucleos(t)ide analog therapy blocks DNA synthesis by the hepatitis B virus (HBV) reverse transcriptase and can control the infection, but treatment is life-long and has high costs and unpredictable long-term side effects.
John E Tavis   +10 more
doaj   +4 more sources

Inhibitors of HIV-1 Reverse Transcriptase—Associated Ribonuclease H Activity [PDF]

open access: goldBiology, 2012
HIV-1 enzyme reverse transcriptase (RT) is a major target for antiviral drug development, with over half of current FDA-approved therapeutics against HIV infection targeting the DNA polymerase activity of this enzyme. HIV-1 RT is a multifunctional enzyme
Michael A. Parniak   +4 more
doaj   +4 more sources

The catalytic mechanism, metal dependence, substrate specificity, and biodiversity of ribonuclease H [PDF]

open access: yesFrontiers in Microbiology, 2022
Ribonucleoside monophosphates are inevitably misincorporated into the DNA genome inside cells, and they need to be excised to avoid chromosome instability.
Jing Pang, Qinyu Guo, Zheng Lu
doaj   +2 more sources

Analogs of the Catechol Derivative Dynasore Inhibit HIV-1 Ribonuclease H, SARS-CoV-2 nsp14 Exoribonuclease, and Virus Replication [PDF]

open access: yesViruses, 2023
Viral replication often depends on RNA maturation and degradation processes catalyzed by viral ribonucleases, which are therefore candidate targets for antiviral drugs.
Abhishek Asthana   +10 more
doaj   +2 more sources

Evolution of ribonuclease H genes in prokaryotes to avoid inheritance of redundant genes [PDF]

open access: goldBMC Evolutionary Biology, 2007
Background A theoretical model of genetic redundancy has proposed that the fates of redundant genes depend on the degree of functional redundancy, and that functionally redundant genes will not be inherited together.
Tomita Masaru   +2 more
doaj   +2 more sources

Discovery of bimodal hepatitis B virus ribonuclease H and capsid assembly inhibitors. [PDF]

open access: yesPLoS Pathogens
Hepatitis B virus (HBV) ribonuclease H (RNaseH) inhibitors are a potent class of antivirals that prevent degradation of the viral pregenomic RNA during reverse transcription and block formation of mature HBV DNAs.
Daniel P Bradley   +9 more
doaj   +2 more sources

1,2,4-Triazolo[1,5-a]pyrimidines as a Novel Class of Inhibitors of the HIV-1 Reverse Transcriptase-Associated Ribonuclease H Activity [PDF]

open access: yesMolecules, 2020
Despite great efforts have been made in the prevention and therapy of human immunodeficiency virus (HIV-1) infection, however the difficulty to eradicate latent viral reservoirs together with the emergence of multi-drug-resistant strains require the ...
Jenny Desantis   +10 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy